Richard S. Geary, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 14,724 shares at $49.29 ($728K) on 2023-12-21, disclosed to the SEC on 2023-12-22.
Scheduled sale ($728k) by EVP, Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.64 | 6,500 | $323K | 44.3% |
| 2 | $49.29 | 4,112 | $203K | 27.8% |
| 3 | $49.29 | 4,112 | $203K | 27.8% |
| Total | $49.44 avg | 14,724 | $728K | 100% |
| Filing → |
| IONS | SELL | 2025-11-03 | $11.9M | — | Filing → |
| IONS | SELL | 2025-10-01 | $7.6M | — | Filing → |
| IONS | SELL | 2025-09-04 | $504K | — | Filing → |